 Equities research analysts predict that CymaBay Therapeutics Inc NASDAQ:CBAY will announce 0.23 earnings per share EPS for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for CymaBay Therapeutics earnings. The lowest EPS estimate is 0.27 and the highest is 0.17. CymaBay Therapeutics reported earnings per share of 0.35 during ... 